ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

American Urological Association Releases New Guideline on Chronic Pelvic Pain in Men

BALTIMORE, April 17, 2025 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA) released the 2025 Guideline on Chronic Pelvic Pain in Men.

This Guideline covers the evaluation and treatment of men who present to a clinician with a complaint of chronic pelvic pain. This Guideline is intended for clinicians evaluating and managing male chronic pelvic pain and includes a discussion of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and chronic scrotal content pain (CSCP).

“Chronic pelvic pain, including chronic prostatitis and chronic scrotal pain, affects millions of men in the United States. The presentation is quite variable, and their management is challenging. This new Guideline provides the much-needed evidence-based approach to the diagnosis and management of male chronic pelvic pain,” said Dr. Henry Lai, chair of the Guideline. “We really wanted to emphasize shared decision-making and a multimodal and multidisciplinary approach to patient care.”

This Guideline has 44 recommendations and is a useful reference for effective evidence-based care related to chronic pelvic pain in men.

This Guideline includes:

  • Recommended approaches to patient evaluation, including discussion of confusable disorders for CP/CPPS and differential diagnosis of scrotal pathology.
  • Review of pelvic floor myalgia and the role of pelvic floor physical therapy.
  • Evaluation of management approaches for pelvic pain with an emphasis on shared decision-making and multi-disciplinary care.
  • Discussion of research gaps and potential future treatment options.

“We usually think of pain in response to tissue injury that resolves with healing, but we now know that pain can also derive from a neurologic origin,” notes Dr. Michel Pontari, co-chair of the Guideline. “As our understanding of the underlying causes of chronic pelvic pain continues to evolve, we’ll gain a greater understanding of effective treatment strategies to improve overall patient quality of life.”

The full guideline is now available at www.auanet.org/ChronicPelvicPain    

A summary of the Guideline also appears at:

Lai HH, Pontari MA, Argoff CE, et al.  Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach. J Urol. 0(0). doi:10.1097/JU.0000000000004564

https://www.auajournals.org/doi/10.1097/JU.0000000000004564

Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Urol. 0(0). doi:10.1097/JU.0000000000004565

https://www.auajournals.org/doi/10.1097/JU.0000000000004565

Lai HH, Pontari MA, Argoff CE, at al. Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain.  J Urol. 0(0). doi:10.1097/JU.0000000000004566

https://www.auajournals.org/doi/10.1097/JU.0000000000004566

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 26,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

Attachment


Corey Del Bianco
American Urological Association
443-689-4033
cdelbianco@auanet.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.